Expertise in
5
conditions

Charles R. Crawley

Cambridge, ENG, GB 
Expertise in
5
conditions
Cambridge, ENG, GB 

Overview

Charles Crawley practices practicing medicine in Cambridge, United Kingdom.

Mr. Crawley is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Leukemia, Follicular Lymphoma, Bone Marrow Transplant, and Orchiectomy.

He is actively involved in clinical research, co-authoring 50 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Cambridge, ENG, United Kingdom
Other Locations
Manchester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation
A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation
Enrollment Status: Completed
Publish Date: August 14, 2026
Intervention Type: Drug
Study Drug: Azacitidine
Study Phase: Phase 3
Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS
Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS
Enrollment Status: Unknown
Publish Date: September 02, 2020
Intervention Type: Other
View 1 Less Clinical Trial

49 Total Publications

The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy.
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy.
Journal: Bone marrow transplantation
Published: March 27, 2026

Frequently Asked Questions about Charles R. Crawley

Is Charles R. Crawley a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Charles R. Crawley is classified as an Distinguished expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Charles R. Crawley participate in research or clinical trials?

Yes. Charles R. Crawley has published 49 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Charles R. Crawley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Crawley's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile